Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27995059 | 0.97 | ALDH1A1 (0.65) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL4187855 | 0.97 | ALDH1A1 (0.65) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL4672998 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL542772 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL14666299 | 0.91 | ALDH1A1 (0.47) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| Bromide SCHEMBL10492652 | 0.91 | DNM1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL9123900 | 0.88 | ALDH1A1 (0.50) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 | |
| SCHEMBL15052279 | 0.87 | SIGMAR1 (0.48) | ALDH1A1SIGMAR1HRH4HRH3SLC2A1 | |
| SCHEMBL234338 | 0.87 | SIGMAR1 (0.48) | ALDH1A1SIGMAR1HRH4HRH3SLC2A1 | |
| SCHEMBL18210639 | 0.86 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1SIGMAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118765309-A | Composition containing high-safety amide compound | 科巨希化学股份有限公司 | 2024-10-11 | — | — | CN | disclosed |
| US-11225507-B2 | Conformation switchable antimicrobial peptides and methods of using the same | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-01-18 | — | — | US | disclosed |
| US-20200399319-A1 | CONFORMATION SWITCHABLE ANTIMICROBIAL PEPTIDES AND METHODS OF USING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2020-12-24 | — | — | US | disclosed |
| EP-2785435-B1 | METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT WITH AN ABSORBENT SOLUTION MADE FROM BIS(AMINO-3-PROPYL)ETHERS OR (AMINO-2-ETHYL)-(AMINO-3-PROPYL)ETHERS | IFP ENERGIES NOW (FR) | 2018-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225507-B2 | Conformation switchable antimicrobial peptides and methods of using the same | VIP, PGC, GIPR | ALDH1A1 4560/4885TSHR 2042/4885DNM1 865/4885 |
| US-20200399319-A1 | CONFORMATION SWITCHABLE ANTIMICROBIAL PEPTIDES AND METHODS OF USING THE SAME | VIP, PGC, GIPR | ALDH1A1 4560/4885TSHR 2042/4885DNM1 865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.